Literature DB >> 10726790

Impaired dark adaptation in polycythemia. Improvement after treatment.

U Havelius1, S Berglund, P Falke, B Hindfelt, T Krakau.   

Abstract

PURPOSE: To determine if dark adaptation is reduced in individuals with polycythemia and if so whether there is any improvement in dark adaptation after treatment.
METHODS: Dark adaptation was recorded monocularly by automatic dark adaptometry in ten consecutive patients with polycythemia before and after treatment. Analogue investigations were performed in 31 healthy control subjects.
RESULTS: Dark adaptation was markedly impaired in the patients as compared with the control subjects. After reduction of the red cell count and normalization of the hematocrit and hemoglobin the dark adaptation was markedly improved. There was no significant change in dark vision in the control subjects negating a confounding learning effect.
CONCLUSION: The findings indicate a sustained but reversible neuronal hypofunction secondary to polycythemia. As the rheological abnormality was normalized, dark adaptation was improved, probably secondary to normalized microcirculation within the retina or the brain, or both, possibly with reactivation of formerly inactive neuronal cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10726790     DOI: 10.1034/j.1600-0420.2000.078001053.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  7 in total

Review 1.  The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment.

Authors:  G B Arden
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

Review 2.  The pathogenesis of early retinal changes of diabetic retinopathy.

Authors:  G B Arden; S Sivaprasad
Journal:  Doc Ophthalmol       Date:  2012-02       Impact factor: 2.379

3.  Two Eyes Are Better Than One-Binocular Summation of Dark Vision in Healthy Individuals and Patients with Chronic Respiratory Disease.

Authors:  Joakim Thylefors; Ulf Havelius
Journal:  Neuroophthalmology       Date:  2014-04-02

Review 4.  Spare the rod and spoil the eye.

Authors:  G B Arden; R L Sidman; W Arap; R O Schlingemann
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

5.  Active HIF-1 in the normal human retina.

Authors:  John M Hughes; Arjan J Groot; Petra van der Groep; René Sersansie; Marc Vooijs; Paul J van Diest; Cornelis J F Van Noorden; Reinier O Schlingemann; Ingeborg Klaassen
Journal:  J Histochem Cytochem       Date:  2009-11-09       Impact factor: 2.479

Review 6.  Hypoxia and Dark Adaptation in Diabetic Retinopathy: Interactions, Consequences, and Therapy.

Authors:  David J Ramsey; G B Arden
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

Review 7.  Rod metabolic demand drives progression in retinopathies.

Authors:  Michael K Lin; Soo Hyun Kim; Lijuan Zhang; Yi-Ting Tsai; Stephen H Tsang
Journal:  Taiwan J Ophthalmol       Date:  2015-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.